Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,430.00    -22.00 (-1.52%)
Bid:
1,430.00
Ask:
1,434.00
Spread: 4.00 (0.28%)
Market Cap: £489.59m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Result of AGM

7 Nov 2018 10:42

RNS Number : 6405G
Craneware plc
07 November 2018
Β 

Craneware plc

("Craneware", "the Group" or the "Company")

Result of AGM

Β 

7 November 2018 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed.

Β 

The proxy voting results are included below.

Β 

Resolution

For

Against

Discretion to Chairman and Third party

Withheld

Total

01

14,155,187

0

1,610

2,114

14,158,911

02

13,685,555

471,246

1,610

500

14,158,911

03

13,993,525

17,835

1,610

145,941

14,158,911

04

13,666,828

490,473

1,610

0

14,158,911

05

14,138,179

19,122

1,610

0

14,158,911

06

14,124,953

32,348

1,610

0

14,158,911

07

9,816,543

4,340,758

1,610

0

14,158,911

08

14,137,743

19,558

1,610

0

14,158,911

09

14,157,179

122

1,610

0

14,158,911

10

8,226,805

5,929,996

1,610

500

14,158,911

11

13,148,275

1,009,026

1,610

0

14,158,911

12

14,141,944

15,357

1,610

0

14,158,911

13

14,157,179

122

1,610

0

14,158,911

14

14,155,999

1,302

1,610

0

14,158,911

15

13,057,491

1,099,810

1,610

0

14,158,911

16

13,747,429

146,112

1,600

263,770

14,158,911

Β 

Β 

For further information, please contact:

Β 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO / Craig Preston, CFO

Peel Hunt (NOMAD and Joint Broker)

+44 (0)20 7418 8900

Dan Webster/ George Sellar / Guy Pengelley

Investec Bank (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb/ Sebastian Lawrence/ Henry Reast

Alma (Financial PR)

+44 (0)7779 664 584

Caroline Forde/ Robyn Fisher/ Josh Royston

Β 

Β 

About Craneware

Β 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Β 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

Β 

Β Learn more at www.craneware.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RAGBGBDBRXGBGIR
Date   Source Headline
20th May 202511:27 amRNSForm 8.5 (EPT/NON-RI)-Craneware plc
20th May 202511:09 amRNSForm 8.5 (EPT/RI)-Craneware plc
20th May 20259:59 amRNSForm 8.5 (EPT/RI) - Craneware PLC
20th May 20259:29 amRNSForm 8.3 - Craneware PLC
19th May 20254:23 pmRNSForm 8.5 (EPT/NON-RI)-Craneware plc
19th May 20254:02 pmRNSForm 8.3 - Craneware plc
19th May 20253:20 pmRNSForm 8.3 - Craneware plc
19th May 20253:16 pmRNSForm 8.3 - CRANEWARE PLC
19th May 20252:29 pmGNWForm 8.3 - Craneware Plc
19th May 20252:08 pmBUSForm 8.3 - Craneware PLC
19th May 20251:45 pmGNWForm 8.3 - Craneware plc - Octopus Investments
19th May 20251:43 pmRNSForm 8.3 - Craneware Plc
19th May 20251:42 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGAML)
19th May 20251:38 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGWL)
19th May 202512:50 pmRNSForm 8.3 - Craneware PLC
19th May 202512:11 pmBUSForm 8.3 - Craneware plc
19th May 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc
19th May 202511:55 amRNSForm 8.3 - Craneware plc
19th May 202511:15 amRNSForm 8.5 (EPT/RI)-Craneware plc
19th May 202511:09 amRNSForm 8.5 (EPT/RI) - CRANEWARE PLC
19th May 202510:31 amRNSForm 8.5 (EPT/RI) - Craneware plc
19th May 20258:57 amGNWForm 8.5 (EPT/RI)-Craneware plc
16th May 20253:16 pmRNSResponse to Statement by Bain Capital
16th May 20251:16 pmRNSForm 8.3 - CRANEWARE PLC
16th May 20259:41 amRNSStatement re Possible Offer
1st May 20253:52 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSPurchase of Shares by Director and TVR
15th Apr 20257:00 amRNSBlock listing Interim Review
21st Mar 20251:50 pmRNSDividend Currency Election
11th Mar 20257:00 amRNSFY25 Interim Results
19th Feb 20253:23 pmRNSNotification of major holdings
13th Jan 20257:00 amRNSH1 FY25 Trading Update
29th Nov 20244:18 pmRNSDividend Currency Election
20th Nov 20241:57 pmRNSHolding(s) in Company
19th Nov 20245:13 pmRNSVesting of Long Term Incentive Plan Awards and TVR
13th Nov 20241:23 pmRNSResult of AGM
13th Nov 20247:00 amRNSAGM Statement and Board Changes
25th Oct 20243:02 pmRNSHolding(s) in Company
16th Oct 20245:05 pmRNSPosting of Annual Report and Notice of AGM
15th Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 202412:30 pmRNSTotal Voting Rights
23rd Sep 20245:31 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSExercise of Share Options
17th Sep 20244:40 pmRNSGrant of Long Term Incentive Plan Awards
12th Sep 20244:50 pmRNSNotification of Major Holdings
11th Sep 20243:45 pmRNSDirector/PDMR Dealings
10th Sep 20247:00 amRNSRelease and discharge of security in the Company
3rd Sep 20247:00 amRNSFY24 Final Results
27th Aug 20247:00 amRNSNotice of Results Presentations
18th Jul 20247:00 amRNSFY24 Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.